Question explored with the scientific record
Conversation so far
- 1 which receptors are likely hit too hard by this combo of meds taken near bedtime: clonazapam .5mg, mirtazapine 30mg, gabapentin 600mg, olanzapine 7.5mg + a private exchange
- 2 what effect do they have on weight both with and without terzepatide 7.5mg + a private exchange
- 3 I forgot to mention belsomra. Its use is intended to allow good sleep while reducing the GABA agonist meds. + a private exchange
- 4 Which alternative antipsychotic could replace olanzapine with least sleep loss? + a private exchange
- 5 Lamotrigine requires long taper up due to SJS risk. Lithium is problematic in a 78 year old with CKD stage 2 + a private exchange
- 6 the effective dose for geriatric cases is lower for lithium than otherwise. The problem is that levels have to be frequently monitored because the minimum therapeutic level, added to dye for procedures, can be toxic to kidneys. It is probably still worth considering. + a private exchange
- 7 you missed the additive effect of other meds secreted by kidney that are used in emergencies (CT, MRI) or for diagnostics.
- 8 in your analyses, do not always comment on the full stack, except where relevant.
- 9 Are there studies on drug accumulation risk in older adults given contrast?
Answered on this page ↓
Are there studies on drug accumulation risk in older adults given contrast?
The short version: no retrieved study tests whether contrast agents increase drug accumulation in older adults on multiple sedating medications, so the answer is mechanism, not measurement.
The retrieval is thin for your exact question. It contains no study of contrast agents combined with sedating CNS drugs in older adults, and no study measuring drug levels before and after contrast exposure. What it does show is that contrast agents can injure the kidney, and the kidney is the bottleneck for drug clearance. Contrast-associated acute kidney injury rose from about 10 in 100 patients in 2013 to 13 in 100 in 2017 in one large angiography cohort [2]. In stroke patients, severe baseline kidney impairment strongly predicted contrast kidney injury, and those who got it had much higher three-month death rates [3]. Contrast agents also directly suppress kidney cell mitochondrial activity and cell proliferation in lab studies [1].
The mechanism you are worried about is real. If contrast damages the kidney, drugs cleared by the kidney stay longer. That is how lithium toxicity happened in a 73-year-old man: acute kidney failure pushed his lithium to a toxic level, and even after dialysis his ataxia persisted [4]. Gabapentin, a common sedating drug in older adults, is cleared renally. The same logic applies: a contrast-induced dip in kidney function could raise gabapentin levels and deepen sedation. But no retrieved study actually measured this in your population.
| Risk layer | What the evidence shows |
|---|---|
| Contrast kidney injury rate | About 10-13 in 100 angiography patients [2] |
| Kidney injury with severe baseline impairment | Strongly predicted, higher death [3] |
| Contrast effect on kidney cells | Suppresses mitochondrial activity [1] |
| Drug accumulation after kidney injury | Documented for lithium in an older adult [4] |
My call: the additive risk is mechanistically plausible but untested in this retrieval. The evidence supports caution in older adults with reduced kidney function, not a measured interaction. Confidence: low, because no study in the retrieval tested your exact combination.
Sources used 4
-
Proximal tubule cell response to radiographic contrast media
This study investigates direct cellular effects of radiographic contrast media on proximal tubule cells, showing that contrast media inhibit mitochondrial enzyme activity and cell proliferation without causing rapid viability loss, accompanied by increased extracellular adenosin…
DOI: 10.1152/ajprenal.2001.280.1.F61 -
Trends in incidence and long-term prognosis of acute kidney injury following coronary angiography in Chinese cohort with 11,943 patients from 2013 to 2017: an observational study
The incidence of contrast-associated acute kidney injury (CA-AKI) significantly increased from 9.7% in 2013 to 13.0% in 2017, while 1-year mortality among CA-AKI patients showed no significant decrease.
DOI: 10.1186/s12882-021-02427-6 -
Contrast-Associated Acute Kidney Injury in Endovascular Thrombectomy Patients With and Without Baseline Renal Impairment
This single-center observational study of 336 ischemic stroke patients treated with endovascular thrombectomy (EVT) assessed the incidence of contrast-associated acute kidney injury (CA-AKI) at 24–72 hours, its association with baseline renal impairment (eGFR), and its impact on…
DOI: 10.1161/STROKEAHA.119.026738 -
Lithium carbonate toxicity in an elderly patient: a case report
A 73-year-old man on long-term lithium for bipolar disorder developed severe lithium toxicity (4.2 mmol/l) with acute renal failure; four hemodialyses reduced levels but lithium rebound and persistent ataxia occurred.
DOI: 10.18203/2319-2003.ijbcp20212091